Auscann Group Holdings Ltd (AC8)

Sydney
0.058
0.000(0.00%)
  • Volume:
    19,524
  • Bid/Ask:
    0.058/0.059
  • Day's Range:
    0.058 - 0.059

AC8 Overview

Prev. Close
0.058
Day's Range
0.058-0.059
Revenue
400K
Open
0.059
52 wk Range
0.057-0.13
EPS
-0.02
Volume
19,524
Market Cap
25.55M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
503,108
P/E Ratio
-
Beta
0.59
1-Year Change
-46.36%
Shares Outstanding
440,547,110
Next Earnings Date
-
What is your sentiment on Auscann Group?
or
Market is currently closed. Voting is open during market hours.

Auscann Group Holdings Ltd News

Auscann Group Holdings Ltd Company Profile

Auscann Group Holdings Ltd Company Profile

Employees
0
Market
Australia

AusCann Group Holdings Limited is an Australia-based company, which is engaged in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals. The Company focuses on providing healthcare professionals and veterinarians with pharmaceutical and nutraceutical products to support the treatment of their patients. Its controlled-dose technology platform, Neuvis, is for delivering cannabinoids to human patients through CannPal Animal Therapeutics Pty Ltd. DermaCann is its lead cannabidiol (CBD) derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. CPAT-01 is a liquid, oral veterinary medicine containing tetrahydrocannabinol (THC) and CBD whole plant extracts in a combined ratio to cure pain and inflammation in dogs. CPAT-01 is in Phase II clinical trials. AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited are its subsidiaries.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Justin
    1
    • Justin
      3